Global Non-Oncology Precision Medicine Market Outlook , 2030
The Global Non-Oncology Precision Medicine Market is projected to reach $110.64 billion by 2030, driven by evolving regulatory frameworks and increased adoption of personalized tre
- Bonafide Trust
- 20-06-2024
- Pages : 108
- Figures : 85
- Tables : 117
- Region : Global
- Category : Lifescience & Healthcare
- Healthcare
The global biosimilars and innovative biological drugs market represents a dynamic intersection of biotechnology, healthcare, and regulatory landscapes. Biosimilars, as biotherapeutic counterparts to original biologic drugs, have emerged as a critical component of healthcare systems, offering cost-effective alternatives while maintaining therapeutic efficacy. On the other hand, innovative biological drugs continue to push the boundaries of medical science, addressing complex diseases and unmet medical needs. This intricate interplay between biosimilars and innovative biologics shapes the overall Market Dynamics, influencing treatment paradigms, healthcare expenditure, and patient access. The global biosimilars and innovative biological drugs market exhibits distinct characteristics across different therapeutic areas. Oncology, immunology, and rheumatology are major segments driving market growth, with a pipeline of innovative biologics and biosimilars in development. The complexity of manufacturing and characterizing biological drugs poses significant challenges, requiring specialized expertise and advanced technologies. Regulatory approval processes for both biosimilars and innovative biologics are rigorous, involving extensive clinical trials and safety assessments. Intellectual property rights and patent protection are critical considerations for pharmaceutical companies, influencing market competition and product lifecycle management. Moreover, the reimbursement landscape varies across countries, impacting drug accessibility and affordability.
According to the research report, “Global Non-Oncology Precision Medicine Market Outlook, 2030” published by Bonafide Research, the market is anticipated to cross USD 110640 Billion by 2030 increasing from US$ 81520 million in 2023. The global non-oncology precision medicine market operates within a complex regulatory environment. Governments worldwide are implementing policies and regulations to support the development and adoption of precision medicine technologies. Regulatory bodies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), play a crucial role in establishing guidelines for the approval and commercialization of precision medicine products. However, the regulatory landscape can be challenging, with varying requirements across different countries. Opportunities for growth in the non-oncology precision medicine market are driven by factors such as increasing prevalence of chronic diseases, advancements in genomic technologies, and the growing emphasis on personalized healthcare. International conferences, symposia, and trade shows serve as platforms for knowledge exchange, networking, and business development. However, the market is also characterized by intense competition, with pharmaceutical companies investing heavily in research and development to create innovative precision medicine solutions. Pricing and reimbursement strategies are critical determinants of market success for non-oncology precision medicine products. While the cost-effectiveness of these products can vary, their ability to provide personalized and effective treatments often justifies premium pricing. However, securing favorable reimbursement policies from healthcare payers can be challenging, particularly in countries with cost-containment measures. Promotion and marketing of non-oncology precision medicine products require a nuanced approach. Building relationships with healthcare professionals, patient advocacy groups, and payers is essential for raising awareness and driving adoption. Digital marketing and social media can also be effective tools for reaching target audiences and promoting the benefits of precision medicine. The global economy, measured by purchasing power parity (PPP), influences the non-oncology precision medicine market. Countries with higher per capita income generally have greater healthcare spending, leading to higher demand for advanced medical technologies. However, access to precision medicine can be limited in lower-income countries due to affordability concerns. Population demographics, including age distribution, disease prevalence, and urbanization, also impact Market Dynamics. An aging population, for instance, increases the demand for chronic disease treatments, creating opportunities for precision medicine solutions.
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download SampleMarket Dynamics
Market Drivers
Technological Advancements: Rapid advancements in genomics, proteomics, and bioinformatics are driving the growth of non-oncology precision medicine. These technologies enable the identification of molecular biomarkers, which are essential for patient stratification and targeted therapy development. Additionally, the development of artificial intelligence and machine learning algorithms is accelerating drug discovery and development processes.
Rising Prevalence of Chronic Diseases: The increasing prevalence of chronic diseases, such as cardiovascular disease, diabetes, and autoimmune disorders, is a major driver for the non-oncology precision medicine market. These conditions often exhibit complex and heterogeneous characteristics, necessitating personalized treatment approaches. Precision medicine offers the potential to improve patient outcomes and reduce healthcare costs by targeting specific patient populations.
Payer Reimbursement and Value-Based Care: The shift towards value-based care models is creating opportunities for non-oncology precision medicine. Payers are increasingly focused on the clinical and economic value of treatments, incentivizing the development of targeted therapies that demonstrate improved outcomes. This trend is driving the adoption of real-world evidence and patient-reported outcomes to demonstrate the value of precision medicine interventions.
Market Challenges
• Data Privacy and Security: The collection and analysis of large amounts of patient data for precision medicine applications raise concerns about data privacy and security. Protecting sensitive patient information is essential to building trust and ensuring the ethical use of data. Developing robust data governance frameworks and implementing advanced security measures are critical to address these challenges.
•
• Access and Equity: Ensuring equitable access to non-oncology precision medicine is a complex challenge. The high cost of diagnostic tests and targeted therapies can create disparities in care. Addressing issues of affordability and accessibility is crucial to maximize the benefits of precision medicine for all patients.
•
• Healthcare System Infrastructure: The successful implementation of non-oncology precision medicine requires a well-developed healthcare infrastructure, including robust electronic health record systems, trained healthcare professionals, and access to specialized diagnostic laboratories. Many healthcare systems face challenges in meeting these requirements, hindering the adoption of precision medicine approaches.
Market Trends
Expansion into Rare Diseases: The non-oncology precision medicine landscape is witnessing a growing emphasis on rare diseases. Advancements in genetic testing and molecular diagnostics are enabling the identification of previously undiagnosed patient populations. This trend is driving the development of targeted therapies and personalized treatment plans for these rare conditions, offering hope to patients with limited treatment options.
Integration of Real-World Data: The utilization of real-world data (RWD) is becoming increasingly crucial in non-oncology precision medicine. By leveraging data from electronic health records, patient registries, and other sources, researchers and healthcare providers can gain valuable insights into disease progression, treatment effectiveness, and patient outcomes. This data-driven approach is accelerating drug development, optimizing treatment decisions, and improving patient care.
Focus on Patient-Centricity: There is a growing recognition of the importance of patient-centricity in non-oncology precision medicine. Patients are becoming more involved in their healthcare decisions, demanding personalized treatment plans and access to information. This trend is driving the development of patient-reported outcome (PRO) measures and patient-centered clinical trials, ultimately leading to improved patient experiences and outcomes.
•
Segmentation Analysis
Precision diagnostics lead in the Global Non-Oncology Precision Medicine Market due to their ability to provide early and accurate disease detection, enabling personalized treatment plans and improved patient outcomes.
The global non-oncology precision medicine market is segmented into four primary types: applied sciences, precision diagnostics, digital health and information technology, and precision therapeutics. While each segment plays a crucial role in advancing personalized healthcare, precision diagnostics stands out as the leading segment due to its foundational importance in the overall precision medicine ecosystem. Precision diagnostics serves as the cornerstone of non-oncology precision medicine, providing the essential data and insights necessary for tailoring treatment plans. It encompasses a wide range of technologies and methodologies, including genomics, proteomics, metabolomics, and imaging, to identify biomarkers and genetic variations associated with specific diseases. These diagnostic tools enable healthcare providers to accurately assess disease risk, diagnose conditions earlier, and select the most appropriate therapeutic interventions. The rapid advancements in diagnostic technologies, such as next-generation sequencing and liquid biopsy, have significantly expanded the scope and accuracy of precision diagnostics. Furthermore, the growing adoption of companion diagnostics, which are designed to identify patients most likely to benefit from specific treatments, has solidified the role of precision diagnostics in the clinical decision-making process. In contrast, while applied sciences contribute to the development of new diagnostic tools and therapeutic approaches, it is a broader category encompassing research and development activities. Digital health and information technology, although rapidly evolving, primarily focus on data management, analysis, and patient engagement. Precision therapeutics, while essential for delivering personalized treatments, relies heavily on the insights generated by precision diagnostics to identify optimal therapeutic targets and develop tailored drug formulations.
Infectious diseases lead in the Global Non-Oncology Precision Medicine Market due to the increasing prevalence of antibiotic-resistant infections and the need for personalized treatment approaches.
The non-oncology precision medicine market is diverse, with applications spanning a wide range of therapeutic areas. Among these, infectious diseases have emerged as a particularly dynamic segment, driven by the increasing prevalence of antimicrobial resistance and the complex nature of infectious pathogens. The application of precision medicine to infectious diseases holds the promise of tailored treatment strategies, improved patient outcomes, and reduced healthcare costs. Unlike traditional antibiotic approaches that target broad bacterial populations, precision medicine in infectious diseases focuses on identifying specific microbial strains and their underlying genetic makeup. This enables the development of targeted therapies that effectively eliminate the pathogen while minimizing collateral damage to the host. Additionally, precision medicine offers the potential to predict disease progression, optimize treatment regimens, and prevent the development of antimicrobial resistance. The rapid evolution of infectious diseases, such as the emergence of new strains and the spread of antibiotic-resistant bacteria, underscores the need for innovative approaches. Genomic sequencing and bioinformatics play crucial roles in identifying genetic markers associated with disease severity and treatment response. While the infectious diseases segment is at the forefront of non-oncology precision medicine, other therapeutic areas are also showing significant promise. Neurology, for example, is benefiting from advancements in understanding the genetic basis of neurological disorders. Precision medicine approaches are being explored for conditions such as epilepsy, Parkinson's disease, and multiple sclerosis. Cardiovascular diseases, another major health burden, are also being targeted with precision medicine strategies, focusing on identifying patients at high risk for adverse events and tailoring preventive measures accordingly. Lifestyle and endocrinology disorders, including diabetes and obesity, are increasingly recognized as complex conditions influenced by genetic and environmental factors. Precision medicine holds the potential to optimize treatment decisions and improve patient outcomes in these areas. Gastroenterology is another field where precision medicine is gaining traction, with applications in inflammatory bowel diseases, liver diseases, and gastrointestinal cancers.
Regional Analysis
North America leads in the Flip Chip market due to its robust healthcare infrastructure, advanced research institutions, and a strong culture of innovation.
North America has emerged as a leading region in the global non-oncology precision medicine market, driven by a confluence of factors. The region boasts a robust healthcare infrastructure, advanced research institutions, and a strong culture of innovation, fostering the development and adoption of precision medicine technologies. The United States, in particular, has been at the forefront of precision medicine initiatives, with significant investments in genomics, bioinformatics, and personalized treatment approaches. The region's well-established healthcare systems and extensive electronic health records (EHRs) provide a solid foundation for precision medicine implementation. EHRs enable the collection and analysis of patient data, facilitating personalized treatment decisions and outcomes research. Additionally, North America has a strong network of academic medical centers and research institutions that collaborate with pharmaceutical and biotechnology companies to develop and commercialize innovative precision medicine solutions. Furthermore, the region's favorable regulatory environment, coupled with a strong intellectual property protection regime, has encouraged investment in precision medicine research and development. The U.S. Food and Drug Administration (FDA) has played a pivotal role in supporting the development and approval of precision medicine therapies, establishing clear guidelines and regulatory pathways.
Table of Contents
- 1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
- 1.8 Market Estimation Caveats
- 2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Non-Oncology Precision Medicine Market Size 2019-2030
- 2.1.2 Non-Oncology Precision Medicine Market Size CAGR by Region 2019 VS 2023 VS 2030
- 2.2 Non-Oncology Precision Medicine Segment by Type
- 2.2.1 Applied Sciences
- 2.2.2 Precision Diagnostics
- 2.2.3 Digital Health and Information Technology
- 2.2.4 Precision Therapeutics
- 2.3 Non-Oncology Precision Medicine Market Size by Type
- 2.3.1 Non-Oncology Precision Medicine Market Size CAGR by Type (2019 VS 2023 VS 2030)
- 2.3.2 Global Non-Oncology Precision Medicine Market Size Market Share by Type (2019-2024)
- 2.4 Non-Oncology Precision Medicine Segment by Application
- 2.4.1 Infectious Diseases
- 2.4.2 Neurology
- 2.4.3 Cardiovascular
- 2.4.4 Lifestyle and Endocrinology
- 2.4.5 Gastroenterology
- 2.4.6 Others
- 2.5 Non-Oncology Precision Medicine Market Size by Application
- 2.5.1 Non-Oncology Precision Medicine Market Size CAGR by Application (2019 VS 2023 VS 2030)
- 2.5.2 Global Non-Oncology Precision Medicine Market Size Market Share by Application (2019-2024)
- 3 Non-Oncology Precision Medicine Market Size by Player
- 3.1 Non-Oncology Precision Medicine Market Size Market Share by Players
- 3.1.1 Global Non-Oncology Precision Medicine Revenue by Players (2019-2024)
- 3.1.2 Global Non-Oncology Precision Medicine Revenue Market Share by Players (2019-2024)
- 3.2 Global Non-Oncology Precision Medicine Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
- 4 Non-Oncology Precision Medicine by Regions
- 4.1 Non-Oncology Precision Medicine Market Size by Regions (2019-2024)
- 4.2 Americas Non-Oncology Precision Medicine Market Size Growth (2019-2024)
- 4.3 APAC Non-Oncology Precision Medicine Market Size Growth (2019-2024)
- 4.4 Europe Non-Oncology Precision Medicine Market Size Growth (2019-2024)
- 4.5 Middle East & Africa Non-Oncology Precision Medicine Market Size Growth (2019-2024)
- 5 Americas
- 5.1 Americas Non-Oncology Precision Medicine Market Size by Country (2019-2024)
- 5.2 Americas Non-Oncology Precision Medicine Market Size by Type (2019-2024)
- 5.3 Americas Non-Oncology Precision Medicine Market Size by Application (2019-2024)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
- 6 APAC
- 6.1 APAC Non-Oncology Precision Medicine Market Size by Region (2019-2024)
- 6.2 APAC Non-Oncology Precision Medicine Market Size by Type (2019-2024)
- 6.3 APAC Non-Oncology Precision Medicine Market Size by Application (2019-2024)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 7 Europe
- 7.1 Europe Non-Oncology Precision Medicine by Country (2019-2024)
- 7.2 Europe Non-Oncology Precision Medicine Market Size by Type (2019-2024)
- 7.3 Europe Non-Oncology Precision Medicine Market Size by Application (2019-2024)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 8 Middle East & Africa
- 8.1 Middle East & Africa Non-Oncology Precision Medicine by Region (2019-2024)
- 8.2 Middle East & Africa Non-Oncology Precision Medicine Market Size by Type (2019-2024)
- 8.3 Middle East & Africa Non-Oncology Precision Medicine Market Size by Application (2019-2024)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
- 9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
- 10 Global Non-Oncology Precision Medicine Market Forecast
- 10.1 Global Non-Oncology Precision Medicine Forecast by Regions (2025-2030)
- 10.1.1 Global Non-Oncology Precision Medicine Forecast by Regions (2025-2030)
- 10.1.2 Americas Non-Oncology Precision Medicine Forecast
- 10.1.3 APAC Non-Oncology Precision Medicine Forecast
- 10.1.4 Europe Non-Oncology Precision Medicine Forecast
- 10.1.5 Middle East & Africa Non-Oncology Precision Medicine Forecast
- 10.2 Americas Non-Oncology Precision Medicine Forecast by Country (2025-2030)
- 10.2.1 United States Non-Oncology Precision Medicine Market Forecast
- 10.2.2 Canada Non-Oncology Precision Medicine Market Forecast
- 10.2.3 Mexico Non-Oncology Precision Medicine Market Forecast
- 10.2.4 Brazil Non-Oncology Precision Medicine Market Forecast
- 10.3 APAC Non-Oncology Precision Medicine Forecast by Region (2025-2030)
- 10.3.1 China Non-Oncology Precision Medicine Market Forecast
- 10.3.2 Japan Non-Oncology Precision Medicine Market Forecast
- 10.3.3 Korea Non-Oncology Precision Medicine Market Forecast
- 10.3.4 Southeast Asia Non-Oncology Precision Medicine Market Forecast
- 10.3.5 India Non-Oncology Precision Medicine Market Forecast
- 10.3.6 Australia Non-Oncology Precision Medicine Market Forecast
- 10.4 Europe Non-Oncology Precision Medicine Forecast by Country (2025-2030)
- 10.4.1 Germany Non-Oncology Precision Medicine Market Forecast
- 10.4.2 France Non-Oncology Precision Medicine Market Forecast
- 10.4.3 UK Non-Oncology Precision Medicine Market Forecast
- 10.4.4 Italy Non-Oncology Precision Medicine Market Forecast
- 10.4.5 Russia Non-Oncology Precision Medicine Market Forecast
- 10.5 Middle East & Africa Non-Oncology Precision Medicine Forecast by Region (2025-2030)
- 10.5.1 Egypt Non-Oncology Precision Medicine Market Forecast
- 10.5.2 South Africa Non-Oncology Precision Medicine Market Forecast
- 10.5.3 Israel Non-Oncology Precision Medicine Market Forecast
- 10.5.4 Turkey Non-Oncology Precision Medicine Market Forecast
- 10.5.5 GCC Countries Non-Oncology Precision Medicine Market Forecast
- 10.6 Global Non-Oncology Precision Medicine Forecast by Type (2025-2030)
- 10.7 Global Non-Oncology Precision Medicine Forecast by Application (2025-2030)
- 11 Key Players Analysis
- 11.1 Abbott Laboratories
- 11.1.1 Abbott Laboratories Company Information
- 11.1.2 Abbott Laboratories Non-Oncology Precision Medicine Product Offered
- 11.1.3 Abbott Laboratories Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2024)
- 11.1.4 Abbott Laboratories Main Business Overview
- 11.1.5 Abbott Laboratories Latest Developments
- 11.2 Agilent Technologies, Inc.
- 11.2.1 Agilent Technologies, Inc. Company Information
- 11.2.2 Agilent Technologies, Inc. Non-Oncology Precision Medicine Product Offered
- 11.2.3 Agilent Technologies, Inc. Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2024)
- 11.2.4 Agilent Technologies, Inc. Main Business Overview
- 11.2.5 Agilent Technologies, Inc. Latest Developments
- 11.3 Asuragen, Inc.
- 11.3.1 Asuragen, Inc. Company Information
- 11.3.2 Asuragen, Inc. Non-Oncology Precision Medicine Product Offered
- 11.3.3 Asuragen, Inc. Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2024)
- 11.3.4 Asuragen, Inc. Main Business Overview
- 11.3.5 Asuragen, Inc. Latest Developments
- 11.4 Almac Group
- 11.4.1 Almac Group Company Information
- 11.4.2 Almac Group Non-Oncology Precision Medicine Product Offered
- 11.4.3 Almac Group Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2024)
- 11.4.4 Almac Group Main Business Overview
- 11.4.5 Almac Group Latest Developments
- 11.5 AstraZeneca PLC
- 11.5.1 AstraZeneca PLC Company Information
- 11.5.2 AstraZeneca PLC Non-Oncology Precision Medicine Product Offered
- 11.5.3 AstraZeneca PLC Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2024)
- 11.5.4 AstraZeneca PLC Main Business Overview
- 11.5.5 AstraZeneca PLC Latest Developments
- 11.6 Bristol Myers Squibb
- 11.6.1 Bristol Myers Squibb Company Information
- 11.6.2 Bristol Myers Squibb Non-Oncology Precision Medicine Product Offered
- 11.6.3 Bristol Myers Squibb Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2024)
- 11.6.4 Bristol Myers Squibb Main Business Overview
- 11.6.5 Bristol Myers Squibb Latest Developments
- 11.7 bioMérieux SA.
- 11.7.1 bioMérieux SA. Company Information
- 11.7.2 bioMérieux SA. Non-Oncology Precision Medicine Product Offered
- 11.7.3 bioMérieux SA. Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2024)
- 11.7.4 bioMérieux SA. Main Business Overview
- 11.7.5 bioMérieux SA. Latest Developments
- 11.8 BGI
- 11.8.1 BGI Company Information
- 11.8.2 BGI Non-Oncology Precision Medicine Product Offered
- 11.8.3 BGI Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2024)
- 11.8.4 BGI Main Business Overview
- 11.8.5 BGI Latest Developments
- 11.9 Danaher Corp.
- 11.9.1 Danaher Corp. Company Information
- 11.9.2 Danaher Corp. Non-Oncology Precision Medicine Product Offered
- 11.9.3 Danaher Corp. Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2024)
- 11.9.4 Danaher Corp. Main Business Overview
- 11.9.5 Danaher Corp. Latest Developments
- 11.10 Illumina, Inc.
- 11.10.1 Illumina, Inc. Company Information
- 11.10.2 Illumina, Inc. Non-Oncology Precision Medicine Product Offered
- 11.10.3 Illumina, Inc. Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2024)
- 11.10.4 Illumina, Inc. Main Business Overview
- 11.10.5 Illumina, Inc. Latest Developments
- 11.11 Invitae Corporation
- 11.11.1 Invitae Corporation Company Information
- 11.11.2 Invitae Corporation Non-Oncology Precision Medicine Product Offered
- 11.11.3 Invitae Corporation Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2024)
- 11.11.4 Invitae Corporation Main Business Overview
- 11.11.5 Invitae Corporation Latest Developments
- 11.12 Opko Health, Inc.
- 11.12.1 Opko Health, Inc. Company Information
- 11.12.2 Opko Health, Inc. Non-Oncology Precision Medicine Product Offered
- 11.12.3 Opko Health, Inc. Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2024)
- 11.12.4 Opko Health, Inc. Main Business Overview
- 11.12.5 Opko Health, Inc. Latest Developments
- 11.13 Teva Pharmaceutical Industries Ltd.
- 11.13.1 Teva Pharmaceutical Industries Ltd. Company Information
- 11.13.2 Teva Pharmaceutical Industries Ltd. Non-Oncology Precision Medicine Product Offered
- 11.13.3 Teva Pharmaceutical Industries Ltd. Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2019-2024)
- 11.13.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
- 11.13.5 Teva Pharmaceutical Industries Ltd. Latest Developments
- 12 Research Findings and Conclusion
List of Tables
Table 1. Non-Oncology Precision Medicine Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Applied Sciences
Table 3. Major Players of Precision Diagnostics
Table 4. Major Players of Digital Health and Information Technology
Table 5. Major Players of Precision Therapeutics
Table 6. Non-Oncology Precision Medicine Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Non-Oncology Precision Medicine Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Non-Oncology Precision Medicine Market Size Market Share by Type (2019-2024)
Table 9. Non-Oncology Precision Medicine Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Non-Oncology Precision Medicine Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Non-Oncology Precision Medicine Market Size Market Share by Application (2019-2024)
Table 12. Global Non-Oncology Precision Medicine Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Non-Oncology Precision Medicine Revenue Market Share by Player (2019-2024)
Table 14. Non-Oncology Precision Medicine Key Players Head office and Products Offered
Table 15. Non-Oncology Precision Medicine Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Non-Oncology Precision Medicine Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Non-Oncology Precision Medicine Market Size Market Share by Regions (2019-2024)
Table 20. Global Non-Oncology Precision Medicine Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Non-Oncology Precision Medicine Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Non-Oncology Precision Medicine Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Non-Oncology Precision Medicine Market Size Market Share by Country (2019-2024)
Table 24. Americas Non-Oncology Precision Medicine Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Non-Oncology Precision Medicine Market Size Market Share by Type (2019-2024)
Table 26. Americas Non-Oncology Precision Medicine Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Non-Oncology Precision Medicine Market Size Market Share by Application (2019-2024)
Table 28. APAC Non-Oncology Precision Medicine Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Non-Oncology Precision Medicine Market Size Market Share by Region (2019-2024)
Table 30. APAC Non-Oncology Precision Medicine Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Non-Oncology Precision Medicine Market Size Market Share by Type (2019-2024)
Table 32. APAC Non-Oncology Precision Medicine Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Non-Oncology Precision Medicine Market Size Market Share by Application (2019-2024)
Table 34. Europe Non-Oncology Precision Medicine Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Non-Oncology Precision Medicine Market Size Market Share by Country (2019-2024)
Table 36. Europe Non-Oncology Precision Medicine Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Non-Oncology Precision Medicine Market Size Market Share by Type (2019-2024)
Table 38. Europe Non-Oncology Precision Medicine Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Non-Oncology Precision Medicine Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Non-Oncology Precision Medicine Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Non-Oncology Precision Medicine Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Non-Oncology Precision Medicine Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Non-Oncology Precision Medicine Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Non-Oncology Precision Medicine Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Non-Oncology Precision Medicine Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Non-Oncology Precision Medicine
Table 47. Key Market Challenges & Risks of Non-Oncology Precision Medicine
Table 48. Key Industry Trends of Non-Oncology Precision Medicine
Table 49. Global Non-Oncology Precision Medicine Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Non-Oncology Precision Medicine Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Non-Oncology Precision Medicine Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Non-Oncology Precision Medicine Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Abbott Laboratories Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 54. Abbott Laboratories Non-Oncology Precision Medicine Product Offered
Table 55. Abbott Laboratories Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Abbott Laboratories Main Business
Table 57. Abbott Laboratories Latest Developments
Table 58. Agilent Technologies, Inc. Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 59. Agilent Technologies, Inc. Non-Oncology Precision Medicine Product Offered
Table 60. Agilent Technologies, Inc. Main Business
Table 61. Agilent Technologies, Inc. Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Agilent Technologies, Inc. Latest Developments
Table 63. Asuragen, Inc. Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 64. Asuragen, Inc. Non-Oncology Precision Medicine Product Offered
Table 65. Asuragen, Inc. Main Business
Table 66. Asuragen, Inc. Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Asuragen, Inc. Latest Developments
Table 68. Almac Group Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 69. Almac Group Non-Oncology Precision Medicine Product Offered
Table 70. Almac Group Main Business
Table 71. Almac Group Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Almac Group Latest Developments
Table 73. AstraZeneca PLC Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 74. AstraZeneca PLC Non-Oncology Precision Medicine Product Offered
Table 75. AstraZeneca PLC Main Business
Table 76. AstraZeneca PLC Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. AstraZeneca PLC Latest Developments
Table 78. Bristol Myers Squibb Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 79. Bristol Myers Squibb Non-Oncology Precision Medicine Product Offered
Table 80. Bristol Myers Squibb Main Business
Table 81. Bristol Myers Squibb Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Bristol Myers Squibb Latest Developments
Table 83. bioMérieux SA. Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 84. bioMérieux SA. Non-Oncology Precision Medicine Product Offered
Table 85. bioMérieux SA. Main Business
Table 86. bioMérieux SA. Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. bioMérieux SA. Latest Developments
Table 88. BGI Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 89. BGI Non-Oncology Precision Medicine Product Offered
Table 90. BGI Main Business
Table 91. BGI Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. BGI Latest Developments
Table 93. Danaher Corp. Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 94. Danaher Corp. Non-Oncology Precision Medicine Product Offered
Table 95. Danaher Corp. Main Business
Table 96. Danaher Corp. Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Danaher Corp. Latest Developments
Table 98. Illumina, Inc. Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 99. Illumina, Inc. Non-Oncology Precision Medicine Product Offered
Table 100. Illumina, Inc. Main Business
Table 101. Illumina, Inc. Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Illumina, Inc. Latest Developments
Table 103. Invitae Corporation Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 104. Invitae Corporation Non-Oncology Precision Medicine Product Offered
Table 105. Invitae Corporation Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Invitae Corporation Main Business
Table 107. Invitae Corporation Latest Developments
Table 108. Opko Health, Inc. Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 109. Opko Health, Inc. Non-Oncology Precision Medicine Product Offered
Table 110. Opko Health, Inc. Main Business
Table 111. Opko Health, Inc. Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. Opko Health, Inc. Latest Developments
Table 113. Teva Pharmaceutical Industries Ltd. Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 114. Teva Pharmaceutical Industries Ltd. Non-Oncology Precision Medicine Product Offered
Table 115. Teva Pharmaceutical Industries Ltd. Main Business
Table 116. Teva Pharmaceutical Industries Ltd. Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 117. Teva Pharmaceutical Industries Ltd. Latest Developments
Table 1. Non-Oncology Precision Medicine Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Applied Sciences
Table 3. Major Players of Precision Diagnostics
Table 4. Major Players of Digital Health and Information Technology
Table 5. Major Players of Precision Therapeutics
Table 6. Non-Oncology Precision Medicine Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Non-Oncology Precision Medicine Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Non-Oncology Precision Medicine Market Size Market Share by Type (2019-2024)
Table 9. Non-Oncology Precision Medicine Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Non-Oncology Precision Medicine Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Non-Oncology Precision Medicine Market Size Market Share by Application (2019-2024)
Table 12. Global Non-Oncology Precision Medicine Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Non-Oncology Precision Medicine Revenue Market Share by Player (2019-2024)
Table 14. Non-Oncology Precision Medicine Key Players Head office and Products Offered
Table 15. Non-Oncology Precision Medicine Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Non-Oncology Precision Medicine Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Non-Oncology Precision Medicine Market Size Market Share by Regions (2019-2024)
Table 20. Global Non-Oncology Precision Medicine Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Non-Oncology Precision Medicine Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Non-Oncology Precision Medicine Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Non-Oncology Precision Medicine Market Size Market Share by Country (2019-2024)
Table 24. Americas Non-Oncology Precision Medicine Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Non-Oncology Precision Medicine Market Size Market Share by Type (2019-2024)
Table 26. Americas Non-Oncology Precision Medicine Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Non-Oncology Precision Medicine Market Size Market Share by Application (2019-2024)
Table 28. APAC Non-Oncology Precision Medicine Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Non-Oncology Precision Medicine Market Size Market Share by Region (2019-2024)
Table 30. APAC Non-Oncology Precision Medicine Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Non-Oncology Precision Medicine Market Size Market Share by Type (2019-2024)
Table 32. APAC Non-Oncology Precision Medicine Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Non-Oncology Precision Medicine Market Size Market Share by Application (2019-2024)
Table 34. Europe Non-Oncology Precision Medicine Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Non-Oncology Precision Medicine Market Size Market Share by Country (2019-2024)
Table 36. Europe Non-Oncology Precision Medicine Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Non-Oncology Precision Medicine Market Size Market Share by Type (2019-2024)
Table 38. Europe Non-Oncology Precision Medicine Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Non-Oncology Precision Medicine Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Non-Oncology Precision Medicine Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Non-Oncology Precision Medicine Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Non-Oncology Precision Medicine Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Non-Oncology Precision Medicine Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Non-Oncology Precision Medicine Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Non-Oncology Precision Medicine Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Non-Oncology Precision Medicine
Table 47. Key Market Challenges & Risks of Non-Oncology Precision Medicine
Table 48. Key Industry Trends of Non-Oncology Precision Medicine
Table 49. Global Non-Oncology Precision Medicine Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Non-Oncology Precision Medicine Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Non-Oncology Precision Medicine Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Non-Oncology Precision Medicine Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Abbott Laboratories Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 54. Abbott Laboratories Non-Oncology Precision Medicine Product Offered
Table 55. Abbott Laboratories Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Abbott Laboratories Main Business
Table 57. Abbott Laboratories Latest Developments
Table 58. Agilent Technologies, Inc. Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 59. Agilent Technologies, Inc. Non-Oncology Precision Medicine Product Offered
Table 60. Agilent Technologies, Inc. Main Business
Table 61. Agilent Technologies, Inc. Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Agilent Technologies, Inc. Latest Developments
Table 63. Asuragen, Inc. Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 64. Asuragen, Inc. Non-Oncology Precision Medicine Product Offered
Table 65. Asuragen, Inc. Main Business
Table 66. Asuragen, Inc. Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Asuragen, Inc. Latest Developments
Table 68. Almac Group Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 69. Almac Group Non-Oncology Precision Medicine Product Offered
Table 70. Almac Group Main Business
Table 71. Almac Group Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Almac Group Latest Developments
Table 73. AstraZeneca PLC Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 74. AstraZeneca PLC Non-Oncology Precision Medicine Product Offered
Table 75. AstraZeneca PLC Main Business
Table 76. AstraZeneca PLC Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. AstraZeneca PLC Latest Developments
Table 78. Bristol Myers Squibb Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 79. Bristol Myers Squibb Non-Oncology Precision Medicine Product Offered
Table 80. Bristol Myers Squibb Main Business
Table 81. Bristol Myers Squibb Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Bristol Myers Squibb Latest Developments
Table 83. bioMérieux SA. Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 84. bioMérieux SA. Non-Oncology Precision Medicine Product Offered
Table 85. bioMérieux SA. Main Business
Table 86. bioMérieux SA. Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. bioMérieux SA. Latest Developments
Table 88. BGI Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 89. BGI Non-Oncology Precision Medicine Product Offered
Table 90. BGI Main Business
Table 91. BGI Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. BGI Latest Developments
Table 93. Danaher Corp. Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 94. Danaher Corp. Non-Oncology Precision Medicine Product Offered
Table 95. Danaher Corp. Main Business
Table 96. Danaher Corp. Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Danaher Corp. Latest Developments
Table 98. Illumina, Inc. Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 99. Illumina, Inc. Non-Oncology Precision Medicine Product Offered
Table 100. Illumina, Inc. Main Business
Table 101. Illumina, Inc. Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Illumina, Inc. Latest Developments
Table 103. Invitae Corporation Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 104. Invitae Corporation Non-Oncology Precision Medicine Product Offered
Table 105. Invitae Corporation Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Invitae Corporation Main Business
Table 107. Invitae Corporation Latest Developments
Table 108. Opko Health, Inc. Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 109. Opko Health, Inc. Non-Oncology Precision Medicine Product Offered
Table 110. Opko Health, Inc. Main Business
Table 111. Opko Health, Inc. Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. Opko Health, Inc. Latest Developments
Table 113. Teva Pharmaceutical Industries Ltd. Details, Company Type, Non-Oncology Precision Medicine Area Served and Its Competitors
Table 114. Teva Pharmaceutical Industries Ltd. Non-Oncology Precision Medicine Product Offered
Table 115. Teva Pharmaceutical Industries Ltd. Main Business
Table 116. Teva Pharmaceutical Industries Ltd. Non-Oncology Precision Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 117. Teva Pharmaceutical Industries Ltd. Latest Developments
List of Figures
Figure 1. Non-Oncology Precision Medicine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Non-Oncology Precision Medicine Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Non-Oncology Precision Medicine Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Non-Oncology Precision Medicine Sales Market Share by Country/Region (2023)
Figure 8. Non-Oncology Precision Medicine Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Non-Oncology Precision Medicine Market Size Market Share by Type in 2023
Figure 10. Non-Oncology Precision Medicine in Infectious Diseases
Figure 11. Global Non-Oncology Precision Medicine Market: Infectious Diseases (2019-2024) & ($ Millions)
Figure 12. Non-Oncology Precision Medicine in Neurology
Figure 13. Global Non-Oncology Precision Medicine Market: Neurology (2019-2024) & ($ Millions)
Figure 14. Non-Oncology Precision Medicine in Cardiovascular
Figure 15. Global Non-Oncology Precision Medicine Market: Cardiovascular (2019-2024) & ($ Millions)
Figure 16. Non-Oncology Precision Medicine in Lifestyle and Endocrinology
Figure 17. Global Non-Oncology Precision Medicine Market: Lifestyle and Endocrinology (2019-2024) & ($ Millions)
Figure 18. Non-Oncology Precision Medicine in Gastroenterology
Figure 19. Global Non-Oncology Precision Medicine Market: Gastroenterology (2019-2024) & ($ Millions)
Figure 20. Non-Oncology Precision Medicine in Others
Figure 21. Global Non-Oncology Precision Medicine Market: Others (2019-2024) & ($ Millions)
Figure 22. Global Non-Oncology Precision Medicine Market Size Market Share by Application in 2023
Figure 23. Global Non-Oncology Precision Medicine Revenue Market Share by Player in 2023
Figure 24. Global Non-Oncology Precision Medicine Market Size Market Share by Regions (2019-2024)
Figure 25. Americas Non-Oncology Precision Medicine Market Size 2019-2024 ($ Millions)
Figure 26. APAC Non-Oncology Precision Medicine Market Size 2019-2024 ($ Millions)
Figure 27. Europe Non-Oncology Precision Medicine Market Size 2019-2024 ($ Millions)
Figure 28. Middle East & Africa Non-Oncology Precision Medicine Market Size 2019-2024 ($ Millions)
Figure 29. Americas Non-Oncology Precision Medicine Value Market Share by Country in 2023
Figure 30. United States Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 31. Canada Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 32. Mexico Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 33. Brazil Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 34. APAC Non-Oncology Precision Medicine Market Size Market Share by Region in 2023
Figure 35. APAC Non-Oncology Precision Medicine Market Size Market Share by Type in 2023
Figure 36. APAC Non-Oncology Precision Medicine Market Size Market Share by Application in 2023
Figure 37. China Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 38. Japan Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 39. Korea Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 40. Southeast Asia Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 41. India Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 42. Australia Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 43. Europe Non-Oncology Precision Medicine Market Size Market Share by Country in 2023
Figure 44. Europe Non-Oncology Precision Medicine Market Size Market Share by Type (2019-2024)
Figure 45. Europe Non-Oncology Precision Medicine Market Size Market Share by Application (2019-2024)
Figure 46. Germany Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 47. France Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 48. UK Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 49. Italy Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 50. Russia Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 51. Middle East & Africa Non-Oncology Precision Medicine Market Size Market Share by Region (2019-2024)
Figure 52. Middle East & Africa Non-Oncology Precision Medicine Market Size Market Share by Type (2019-2024)
Figure 53. Middle East & Africa Non-Oncology Precision Medicine Market Size Market Share by Application (2019-2024)
Figure 54. Egypt Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 55. South Africa Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 56. Israel Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 57. Turkey Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 58. GCC Country Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 59. Americas Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 60. APAC Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 61. Europe Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 62. Middle East & Africa Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 63. United States Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 64. Canada Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 65. Mexico Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 66. Brazil Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 67. China Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 68. Japan Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 69. Korea Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 70. Southeast Asia Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 71. India Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 72. Australia Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 73. Germany Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 74. France Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 75. UK Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 76. Italy Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 77. Russia Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 78. Spain Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 79. Egypt Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 80. South Africa Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 81. Israel Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 82. Turkey Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 83. GCC Countries Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 84. Global Non-Oncology Precision Medicine Market Size Market Share Forecast by Type (2025-2030)
Figure 85. Global Non-Oncology Precision Medicine Market Size Market Share Forecast by Application (2025-2030)
"
Figure 1. Non-Oncology Precision Medicine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Non-Oncology Precision Medicine Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Non-Oncology Precision Medicine Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Non-Oncology Precision Medicine Sales Market Share by Country/Region (2023)
Figure 8. Non-Oncology Precision Medicine Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Non-Oncology Precision Medicine Market Size Market Share by Type in 2023
Figure 10. Non-Oncology Precision Medicine in Infectious Diseases
Figure 11. Global Non-Oncology Precision Medicine Market: Infectious Diseases (2019-2024) & ($ Millions)
Figure 12. Non-Oncology Precision Medicine in Neurology
Figure 13. Global Non-Oncology Precision Medicine Market: Neurology (2019-2024) & ($ Millions)
Figure 14. Non-Oncology Precision Medicine in Cardiovascular
Figure 15. Global Non-Oncology Precision Medicine Market: Cardiovascular (2019-2024) & ($ Millions)
Figure 16. Non-Oncology Precision Medicine in Lifestyle and Endocrinology
Figure 17. Global Non-Oncology Precision Medicine Market: Lifestyle and Endocrinology (2019-2024) & ($ Millions)
Figure 18. Non-Oncology Precision Medicine in Gastroenterology
Figure 19. Global Non-Oncology Precision Medicine Market: Gastroenterology (2019-2024) & ($ Millions)
Figure 20. Non-Oncology Precision Medicine in Others
Figure 21. Global Non-Oncology Precision Medicine Market: Others (2019-2024) & ($ Millions)
Figure 22. Global Non-Oncology Precision Medicine Market Size Market Share by Application in 2023
Figure 23. Global Non-Oncology Precision Medicine Revenue Market Share by Player in 2023
Figure 24. Global Non-Oncology Precision Medicine Market Size Market Share by Regions (2019-2024)
Figure 25. Americas Non-Oncology Precision Medicine Market Size 2019-2024 ($ Millions)
Figure 26. APAC Non-Oncology Precision Medicine Market Size 2019-2024 ($ Millions)
Figure 27. Europe Non-Oncology Precision Medicine Market Size 2019-2024 ($ Millions)
Figure 28. Middle East & Africa Non-Oncology Precision Medicine Market Size 2019-2024 ($ Millions)
Figure 29. Americas Non-Oncology Precision Medicine Value Market Share by Country in 2023
Figure 30. United States Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 31. Canada Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 32. Mexico Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 33. Brazil Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 34. APAC Non-Oncology Precision Medicine Market Size Market Share by Region in 2023
Figure 35. APAC Non-Oncology Precision Medicine Market Size Market Share by Type in 2023
Figure 36. APAC Non-Oncology Precision Medicine Market Size Market Share by Application in 2023
Figure 37. China Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 38. Japan Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 39. Korea Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 40. Southeast Asia Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 41. India Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 42. Australia Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 43. Europe Non-Oncology Precision Medicine Market Size Market Share by Country in 2023
Figure 44. Europe Non-Oncology Precision Medicine Market Size Market Share by Type (2019-2024)
Figure 45. Europe Non-Oncology Precision Medicine Market Size Market Share by Application (2019-2024)
Figure 46. Germany Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 47. France Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 48. UK Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 49. Italy Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 50. Russia Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 51. Middle East & Africa Non-Oncology Precision Medicine Market Size Market Share by Region (2019-2024)
Figure 52. Middle East & Africa Non-Oncology Precision Medicine Market Size Market Share by Type (2019-2024)
Figure 53. Middle East & Africa Non-Oncology Precision Medicine Market Size Market Share by Application (2019-2024)
Figure 54. Egypt Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 55. South Africa Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 56. Israel Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 57. Turkey Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 58. GCC Country Non-Oncology Precision Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 59. Americas Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 60. APAC Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 61. Europe Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 62. Middle East & Africa Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 63. United States Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 64. Canada Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 65. Mexico Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 66. Brazil Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 67. China Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 68. Japan Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 69. Korea Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 70. Southeast Asia Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 71. India Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 72. Australia Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 73. Germany Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 74. France Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 75. UK Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 76. Italy Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 77. Russia Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 78. Spain Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 79. Egypt Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 80. South Africa Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 81. Israel Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 82. Turkey Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 83. GCC Countries Non-Oncology Precision Medicine Market Size 2025-2030 ($ Millions)
Figure 84. Global Non-Oncology Precision Medicine Market Size Market Share Forecast by Type (2025-2030)
Figure 85. Global Non-Oncology Precision Medicine Market Size Market Share Forecast by Application (2025-2030)
"
Related Reports
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information
Safe and Secure SSL Encrypted
Quick Contacts
Want to customize this report?
We offer 10% Free Customization at the time of purchase
Get Free Customization
Trusted Partners
Budget constraints? Get in touch with us for special pricing
Request DiscountOrder Detail
- Order Placed (09 May, 2026)
- Notify To Team (09 May, 2026)
- Report updation (10 May, 2026)
- Report Quality Check (10 May, 2026)
- Report Dispatch (11 May, 2026)
- Hard Copy
Recently Viewed Products
Global Non-Oncology Precision Medicine Market Outlook , 2030
We are friendly and approachable, give us a call.